AbCellera Biologics (ABCL) Interest Expenses (2020 - 2026)

AbCellera Biologics' (ABCL) quarterly Interest Expenses came in at $3.7 million in Q1 2026, down 93.44% on a QoQ basis from $56.2 million in Q4 2025.

AbCellera Biologics (ABCL) Interest Expenses (2020 - 2026) Analysis & Trends

AbCellera Biologics (ABCL) has 7 years of Interest Expenses data on file, last reported at $3.7 million in Q1 2026.

  • Quarterly Interest Expenses changed N/A year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (changed N/A YoY) and the FY2025 annual result came in at $56.2 million, up 12.67% from the prior year.
  • Interest Expenses slipped to $3.7 million in Q1 2026, from $56.2 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $56.2 million in Q4 2025 to a low of $3.7 million in Q1 2026.
  • A 5-year average of $13.8 million and a median of $4.2 million in 2022 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2022 — Interest Expenses soared 13311.0% — and 2023, when it slumped 72.22%.
  • Tracing ABCL's Interest Expenses over 5 years: stood at $13.4 million in 2022, then tumbled by 72.22% to $3.7 million in 2023, then jumped by 1239.84% to $49.9 million in 2024, then climbed by 12.67% to $56.2 million in 2025, then sank by 93.44% to $3.7 million in 2026.
  • The last three Interest Expenses figures came in at $3.7 million (Q1 2026), $56.2 million (Q4 2025), and $49.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 439.40 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 52.50 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.70 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 39.74 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 335,572.77
7 Royalty Pharma 33.72 Bn 35.84 Bn - 218.10 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 82.05 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 20.27 Mn
10 AbCellera Biologics 3.49 Bn 3.49 Bn - 3.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.34 Mn
Jun 30, 2026 3.34 Mn
Mar 31, 2026 3.69 Mn
Mar 31, 2026 3.69 Mn
Dec 31, 2025 56.23 Mn
Dec 31, 2025 56.23 Mn
Dec 31, 2024 49.91 Mn
Dec 31, 2024 49.91 Mn
Dec 31, 2023 3.73 Mn
Dec 31, 2023 3.73 Mn
Sep 30, 2023 4.30 Mn
Sep 30, 2023 4.30 Mn
Jun 30, 2023 4.30 Mn
Jun 30, 2023 4.30 Mn
Mar 31, 2023 4.24 Mn
Mar 31, 2023 4.24 Mn
Dec 31, 2022 13.41 Mn
Dec 31, 2022 13.41 Mn
Sep 30, 2022 4.24 Mn
Sep 30, 2022 4.24 Mn